You searched for lung cancer | Page 28 of 177

Roche Receives FDA Nod for Lung Cancer Companion Diagnostic

Posted by Chris Wolski | May 20, 2025 | Lung Cancer |

The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.

Posted by Chris Wolski | May 13, 2025 | Cancer |

Oncologists are seeing more advanced cancer cases due to screening barriers and are concerned current tests aren’t effective enough.

Posted by Chris Wolski | May 7, 2025 | Cancer |

New predictive algorithms using routine health data and blood tests significantly improve early detection of 15 cancers.

Posted by Chris Wolski | May 5, 2025 | Lung Cancer |

Roche’s VENTANA TROP2 RxDx Device, a computational companion diagnostic, has received FDA Breakthrough Device Designation.

Posted by Chris Wolski | Apr 22, 2025 | Cancer |

Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.